Table 1 Demographic and clinical characteristics of individuals with iSSDs and HCs.

From: Further clarification of cognitive processes of prospective memory in schizophrenia by comparing eye-tracking and ecologically-valid measurements

 

iSSDs (n = 32)

HCs (n = 32)

Statistics

df

P value

N

Percent

N

Percent

X²

Men

14

43.75

12

37.50

0.259

1

0.611

on ACM

9

28.1

-

-

-

-

-

 

Mean

SD

Mean

SD

t

df

P value

Age (years)

31.97

8.00

30.59

7.05

0.730

62

0.468

IQ

105.31

9.82

109.39

10.66

−0.683

62

0.497

Education (years)

14.75

4.06

15.38

3.20

−1.594

62

0.116

Course of illness (years)

6.46

6.67

-

-

-

-

-

PANSS-positive

12.22

5.43

-

-

-

-

-

PANSS-negative

14.53

4.82

-

-

-

-

-

PANSS-general

25.91

7.63

-

-

-

-

-

PANSS-total

52.66

15.52

-

-

-

-

-

Medication (CPZ eq mg/day)

388.01

259.20

-

-

-

-

-

  1. SSDs Patients with schizophrenia spectrum disorders, HCs Healthy controls, ACM anticholinergic medication, IQ intelligence quotient, PANSS Positive and Negative Syndrome Scale, PANSS-positive Positive subscale score of the PANSS, PANSS-negative Negative subscale score of the PANSS, PANSS-general General psychopathology subscale score of the PANSS, PANSS-total Total score of the PANSS, CPZ eq Chlorpromazine equivalence, SD Standard deviation.
Back to article page